Evidence map›Paper›PMID 29805036›Full record

ArticleCell chemical biology2018

PD

Kimberly Pistorius, Patricia R Souza, Roberta De Matteis, Shani Austin-Williams, Karoline G Primdahl, Anders Vik, Francesca Mazzacuva, Romain A Colas, Raquel M Marques, Trond V Hansen and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Expression and function of resolvin RvD1European journal of oral sciences · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Loss of 15-lipoxygenase disrupts TCell death and differentiation · 2021
    Article
  19. Biochemistry · 2021
    Article
  20. A new synthetic protectin D1 analog 3-oxa-PD1Organic & biomolecular chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Kimberly PistoriusWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Patricia R SouzaWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Roberta De MatteisWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Shani Austin-WilliamsWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Karoline G PrimdahlSchool of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068 Blindern, Oslo 0316, Norway.
Anders VikSchool of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068 Blindern, Oslo 0316, Norway.
Francesca MazzacuvaWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Romain A ColasWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Raquel M MarquesWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Trond V HansenSchool of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068 Blindern, Oslo 0316, Norway.
Jesmond DalliWilliam Harvey Research Institute and John Vane Science Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: j.dalli@qmul.ac.uk.
Queen Mary University of London · GBUniversity of Oslo · NO

Funding

European Research Council 677542Wellcome TrustWellcome Trust 107613/Z/15/Z
6 · The paper itself

Abstract

Macrophages are central in orchestrating the clearance of apoptotic cells and cellular debris during inflammation, with the mechanism(s) regulating this process remaining of interest. Herein, we found that the n-3 docosapentaenoic acid-derived protectin (PD

Indexed as

Cell DifferentiationArachidonate 15-LipoxygenaseCD59 AntigensFatty Acids, UnsaturatedHealthy VolunteersHumansLeukocytes, MononuclearLipoxygenase InhibitorsMacrophagesMolecular StructureStereoisomerismArachidonate 15-LipoxygenaseCD59 Antigensdocosapentaenoic acidFatty Acids, UnsaturatedLipoxygenase Inhibitorslipid mediatorsomega-3resolutiontotal organic synthesis

Identifiers

PMID29805036
PMCPMC6024030
OpenAlexW2803887211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.